---
figid: PMC2674225__PROCATS62152f2
figtitle: Repression of TGFB-RII and abrogated signaling through the Smad pathway
organisms:
- NA
pmcid: PMC2674225
filename: PROCATS62152f2.jpg
figlink: /pmc/articles/PMC2674225/figure/fig2/
number: F2
caption: Classification of lung adenocarcinoma reflects progression along a spectrum
  of invasiveness spanning epithelial atypia, bronchioloalveolar adenocarcinoma (BAC),
  BAC with foci of microinvasion, and invasive adenocarcinoma. In cells with repression
  of TGFβ-RII (lower panel), signaling through the Smad pathway is abrogated (right).
  Invasiveness is mediated through noncanonical signaling pathways that require RANTES
  (left).
papertitle: Genomics of Lung Cancer.
reftext: Alain C. Borczuk, et al. Proc Am Thorac Soc. 2009 Apr 15;6(2):152-158.
year: '2009'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.890362
figid_alias: PMC2674225__F2
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC2674225__F2
ndex: 7fa360f9-de8d-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC2674225__PROCATS62152f2.html
  '@type': Dataset
  description: Classification of lung adenocarcinoma reflects progression along a
    spectrum of invasiveness spanning epithelial atypia, bronchioloalveolar adenocarcinoma
    (BAC), BAC with foci of microinvasion, and invasive adenocarcinoma. In cells with
    repression of TGFβ-RII (lower panel), signaling through the Smad pathway is abrogated
    (right). Invasiveness is mediated through noncanonical signaling pathways that
    require RANTES (left).
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - TGFB1
  - TGFB2
  - TGFB3
  - EGF
  - IFNG
  - TNF
  - TGFBR1
  - TGFBR2
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - JAK1
  - NFKB1
  - RELA
  - RELB
  - REL
  - NFKB2
  - SMAD2
  - SMAD3
  - STAT1
  - KRAS
  - HRAS
  - NRAS
  - RHOA
  - MAP3K7
  - NR2C2
  - SMAD4
  - EPHB2
  - MSH6
  - MYBBP1A
  - PELP1
  - ROCK1
  - ROCK2
  - CRK
  - AIMP2
  - GRAP2
  - AHSA1
  - POLDIP2
  - SMAD7
  - CCL5
  - Cancer
---
